[Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus]. 1980

H Bour

UI MeSH Term Description Entries
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005907 Gliclazide An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Diabrezide,Diaglyk,Diaikron,Diamicron,Gen-Gliclazide,Gliklazid,Glyade,Glyclazide,Novo-Gliclazide,S-1702,S-852,Gen Gliclazide,Novo Gliclazide,S 1702,S 852,S1702,S852
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

H Bour
January 1988, Advances in experimental medicine and biology,
H Bour
January 1986, Journees annuelles de diabetologie de l'Hotel-Dieu,
H Bour
December 1983, The Tohoku journal of experimental medicine,
H Bour
January 1995, The National medical journal of India,
H Bour
January 1988, Journees annuelles de diabetologie de l'Hotel-Dieu,
H Bour
May 1988, Bailliere's clinical endocrinology and metabolism,
H Bour
January 1995, Journees annuelles de diabetologie de l'Hotel-Dieu,
Copied contents to your clipboard!